Mercury Laboratories Reports 183% Jump in Net Profit with Strong Revenue Growth
Mercury Laboratories Limited reported strong financial results for the recent quarter. Total revenue increased by 8.9% to ₹18.32 crore, while net profit after tax surged by 183.3% to ₹96.76 lakh. The EBITDA margin expanded to 13.9% from 10.5%. Revenue from operations grew by 8.7% to ₹18.14 crore. The company's performance was attributed to higher operating leverage, improved cost management, and a favorable product mix. Despite increases in material costs and employee expenses, effective cost control measures led to a 9.4% decrease in other expenses to ₹4.29 crore.
*this image is generated using AI for illustrative purposes only.
Mercury Laboratories Limited, a pharmaceutical company, has reported robust financial results for the recent quarter, showcasing significant growth in both revenue and profitability.
Financial Highlights
- Total revenue increased by 8.9% year-over-year to ₹18.32 crore
- Net profit after tax surged by 183.3% to ₹96.76 lakh
- EBITDA margin expanded to 13.9% from 10.5% in the same quarter last year
- Revenue from operations grew by 8.7% to ₹18.14 crore
- Other income rose by 20.8% to ₹18.10 lakh
Operational Performance
The company's impressive financial performance can be attributed to several factors:
Higher Operating Leverage: Mercury Laboratories effectively utilized its existing resources to generate more revenue without a proportional increase in costs.
Improved Cost Management: The company implemented successful cost control measures, as evidenced by a 9.4% decrease in other expenses to ₹4.29 crore.
Favorable Product Mix: The shift towards higher-margin products contributed to the substantial improvement in profitability.
Cost Analysis
While Mercury Laboratories demonstrated strong overall performance, some cost components did see increases:
- Cost of materials consumed rose by 27.8% to ₹5.94 crore
- Employee expenses increased by 10.4% to ₹4.24 crore
Despite these increases, the company's effective cost management strategies and revenue growth led to a significant expansion in profitability.
Key Financial Metrics
| Metric | Value | Change |
|---|---|---|
| Total Revenue | ₹18.32 crore | +8.9% |
| Net Profit After Tax | ₹96.76 lakh | +183.3% |
| EBITDA Margin | 13.9% | +3.4 percentage points |
| Revenue from Operations | ₹18.14 crore | +8.7% |
| Other Income | ₹18.10 lakh | +20.8% |
| Cost of Materials Consumed | ₹5.94 crore | +27.8% |
| Employee Expenses | ₹4.24 crore | +10.4% |
| Other Expenses | ₹4.29 crore | -9.4% |
The paid-up equity share capital of Mercury Laboratories remained unchanged at ₹1.20 crore.
This quarter's results demonstrate Mercury Laboratories' ability to drive revenue growth while significantly improving its bottom line through operational efficiencies and strategic product positioning.
Historical Stock Returns for Mercury Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.61% | -6.29% | -3.76% | +0.12% | -17.05% | +104.31% |
19
